title: New cervical cancer screening guidelines, again.
abstract: Guidelines for cervical cancer screening have continued to evolve as we have accumulated new information about the pathogenesis of cervical cancer and the role of the human papilloma virus. Most recently, the American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology issued revised joint recommendations for the prevention and early detection of cervical cancer. In addition, the US Preventative Services Task Force revised its guidelines, and the American College of Obstetricians and Gynecologists updated its practice bulletin.
authors.affiliation: Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
authors.forename: Nicole
authors.initials: N
authors.lastname: Karjane
authors.forename: David
authors.initials: D
authors.lastname: Chelmow
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000821:virology; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008403:Mass Screening / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D008875:Middle Aged; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000175:diagnosis; D053918:Papillomavirus Vaccines; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D014625:Vaginal Neoplasms / Q000175:diagnosis; D014626:Vaginal Smears; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000473:pathology / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines